Total Payments
$1,256
2024 Payments
$397.93
Companies
10
Transactions
29
Medicare Patients
1,481
Medicare Billing
$97,451
Payment Breakdown by Category
Food & Beverage$1,256 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,256 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Oyster Point Pharma, Inc. | $368.02 | 9 | $0 (2024) |
| Amgen Inc. | $228.60 | 6 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $140.47 | 2 | $0 (2022) |
| Aerie Pharmaceuticals, Inc. | $124.99 | 1 | $0 (2018) |
| Allergan Inc. | $124.99 | 1 | $0 (2017) |
| Johnson & Johnson Surgical Vision, Inc. | $117.10 | 2 | $0 (2019) |
| Horizon Therapeutics plc | $99.03 | 5 | $0 (2023) |
| Kala Pharmaceuticals, Inc. | $22.46 | 1 | $0 (2021) |
| Mallinckrodt Hospital Products Inc. | $15.57 | 1 | $0 (2022) |
| Thea Pharma Inc. | $15.22 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $397.93 | 10 | Amgen Inc. ($228.60) |
| 2023 | $247.91 | 8 | Oyster Point Pharma, Inc. ($198.69) |
| 2022 | $96.07 | 5 | Horizon Therapeutics plc ($65.03) |
| 2021 | $22.46 | 1 | Kala Pharmaceuticals, Inc. ($22.46) |
| 2019 | $242.10 | 3 | Sun Pharmaceutical Industries Inc. ($125.00) |
| 2018 | $124.99 | 1 | Aerie Pharmaceuticals, Inc. ($124.99) |
| 2017 | $124.99 | 1 | Allergan Inc. ($124.99) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/22/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Dry eyes | ||||||
| 08/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/24/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/17/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $104.57 | General |
| Category: Dry eyes | ||||||
| 05/28/2024 | Oyster Point Pharma, Inc. | RYZUMVI (Drug), Tyrvaya | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Pharmacologically-induced mydriasis | ||||||
| 04/03/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/20/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/08/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Dry eyes | ||||||
| 11/28/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: DRY EYE | ||||||
| 08/28/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: DRY EYE | ||||||
| 08/23/2023 | Thea Pharma Inc. | — | Food and Beverage | In-kind items and services | $15.22 | General |
| 05/24/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: TEPEZZA | ||||||
| 05/24/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: DRY EYE | ||||||
| 05/03/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $84.47 | General |
| Category: DRY EYE | ||||||
| 04/28/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: TEPEZZA | ||||||
| 03/29/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $61.80 | General |
| Category: DRY EYE | ||||||
| 11/01/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: TEPEZZA | ||||||
| 08/29/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: TEPEZZA | ||||||
| 08/23/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: TEPEZZA | ||||||
| 04/19/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Ophthalmology | ||||||
| 05/27/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Ocular | ||||||
| 11/13/2019 | Johnson & Johnson Surgical Vision, Inc. | — | Food and Beverage | In-kind items and services | $13.73 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 507 | 534 | $83,475 | $32,127 |
| 2022 | 9 | 414 | 462 | $71,725 | $29,463 |
| 2021 | 6 | 316 | 343 | $51,370 | $20,329 |
| 2020 | 6 | 244 | 271 | $43,983 | $15,532 |
Total Patients
1,481
Total Services
1,610
Medicare Billing
$97,451
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 105 | $20,475 | $10,455 | 51.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 75 | 79 | $11,850 | $6,192 | 52.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 89 | 104 | $11,960 | $4,481 | 37.5% |
| 92250 | Photography of the retina | Office | 2023 | 120 | 122 | $21,960 | $3,959 | 18.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $5,400 | $3,353 | 62.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 43 | 44 | $5,280 | $2,147 | 40.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 36 | 37 | $3,700 | $890.47 | 24.1% |
| 92025 | Ct scan of cornea | Office | 2023 | 19 | 19 | $2,850 | $650.30 | 22.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 136 | 178 | $26,700 | $12,498 | 46.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 81 | $15,795 | $7,706 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $4,950 | $2,929 | 59.2% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 43 | 46 | $5,520 | $2,217 | 40.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 19 | 19 | $3,800 | $1,736 | 45.7% |
| 92250 | Photography of the retina | Office | 2022 | 32 | 32 | $5,760 | $1,083 | 18.8% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 55 | 55 | $5,500 | $615.59 | 11.2% |
| 92025 | Ct scan of cornea | Office | 2022 | 16 | 16 | $2,400 | $417.58 | 17.4% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 13 | 13 | $1,300 | $261.64 | 20.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 111 | 136 | $15,640 | $6,511 | 41.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 63 | $12,315 | $6,469 | 52.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 29 | 29 | $6,525 | $3,248 | 49.8% |
| 92250 | Photography of the retina | Office | 2021 | 57 | 58 | $10,445 | $1,912 | 18.3% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 34 | 34 | $4,145 | $1,885 | 45.5% |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | Office | 2021 | 23 | 23 | $2,300 | $303.45 | 13.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 66 | 77 | $15,015 | $6,174 | 41.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 80 | $13,305 | $4,990 | 37.5% |
About Dr. Barbara Devane, D.O
Dr. Barbara Devane, D.O is a Ophthalmology healthcare provider based in Concord, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1043483944.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Devane, D.O has received a total of $1,256 in payments from pharmaceutical and medical device companies, with $397.93 received in 2024. These payments were reported across 29 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,256).
As a Medicare-enrolled provider, Devane has provided services to 1,481 Medicare beneficiaries, totaling 1,610 services with total Medicare billing of $97,451. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Concord, CA
- Active Since 04/11/2008
- Last Updated 04/11/2008
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1043483944
Products in Payments
- TYRVAYA (Drug) $351.78
- TEPEZZA (Biological) $228.60
- CEQUA (Drug) $125.00
- OZURDEX (Drug) $124.99
- Rhopressa (Drug) $124.99
- Catalys Laser System (Device) $103.37
- TEPEZZA (Drug) $99.03
- INVELTYS (Drug) $22.46
- RYZUMVI (Drug) $16.24
- ACTHAR (Biological) $15.57
- Cequa (Drug) $15.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Concord
David Weinberg, Md, MD
Ophthalmology — Payments: $57,670
Ophthalmology $57,670
Joshua Rheinbolt, Md, MD
Ophthalmology — Payments: $7,750
Ophthalmology $7,750
Dr. Karen Graham, Md, MD
Ophthalmology — Payments: $6,345
Ophthalmology $6,345
Dr. Arun Prasad, Md, MD
Ophthalmology — Payments: $6,043
Ophthalmology $6,043
Dr. Clark Tsai, M.d, M.D
Ophthalmology — Payments: $5,618
Ophthalmology $5,618
Jerome Ramos Esteban, Md, MD
Ophthalmology — Payments: $2,900
Ophthalmology $2,900